{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:08:20Z","timestamp":1787742500677,"version":"build-2784847793"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005992","name":"Republic of Bulgaria Ministry of Education and Science","doi-asserted-by":"publisher","award":["KP-06-DV-3\/15.12.2021"],"award-info":[{"award-number":["KP-06-DV-3\/15.12.2021"]}],"id":[{"id":"10.13039\/501100005992","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejps.2025.107150","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:28:47Z","timestamp":1749580127000},"page":"107150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Tiny-TIM intestinal fluids versus human intestinal fluids: A comparison of their composition and solubilizing capacity for poorly soluble drugs"],"prefix":"10.1016","volume":"211","author":[{"given":"Brecht","family":"Goovaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro L\u00f3pez","family":"M\u00e1rmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahari","family":"Vinarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anura S.","family":"Indulkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Borchardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-388X","authenticated-orcid":false,"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Koziolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejps.2025.107150_bib0001","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1002\/jps.24177","article-title":"Application and validation of an advanced gastrointestinal in vitro model for the evaluation of drug product performance in pharmaceutical development","volume":"103","author":"Barker","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.ejps.2025.107150_bib0002","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.xphs.2020.08.008","article-title":"A retrospective biopharmaceutical analysis of >800 approved oral drug products: are drug properties of solid dispersions and lipid-based formulations distinctive?","volume":"109","author":"Bennett-Lenane","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2025.107150_bib0003","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/mp300487u","article-title":"Correlation between molecular mobility and physical stability of amorphous itraconazole","volume":"10","author":"Bhardwaj","year":"2013","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ejps.2025.107150_bib0004","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1023\/B:PHAM.0000022404.70478.4b","article-title":"A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions","volume":"21","author":"Blanquet","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107150_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.104967","article-title":"Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems","volume":"137","author":"Boyd","year":"2019","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2025.107150_bib0007","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2018.12.010","article-title":"In vitro models for the prediction of in vivo performance of oral dosage forms: recent progress from partnership through the IMI OrBiTo collaboration","volume":"136","author":"Butler","year":"2019","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"issue":"7","key":"10.1016\/j.ejps.2025.107150_bib0008","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.xphs.2022.01.024","article-title":"Evaluating the IVIVC by combining tiny-tim outputs and compartmental PK model to predict oral exposure for different formulations of ibuprofen","volume":"111","author":"Chiang","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2025.107150_bib0009","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1208\/s12248-012-9333-x","article-title":"An investigation into the utility of a multi-compartmental, dynamic, system of the upper gastrointestinal tract to support formulation development and establish bioequivalence of poorly soluble drugs","volume":"14","author":"Dickinson","year":"2012","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.ejps.2025.107150_bib0010","first-page":"223","article-title":"Food-effect bioavailability and fed bioequivalence studies","volume":"34","year":"2002","journal-title":"J. Korean Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2025.107150_bib0011","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.4c00944","article-title":"Understanding the impact of lipids on the solubilizing capacity of human intestinal fluids","author":"Goovaerts","year":"2024","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.ejps.2025.107150_bib0013","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/bi00460a012","article-title":"Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings","volume":"29","author":"Hernell","year":"1990","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.ejps.2025.107150_bib0014","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2013.04.003","article-title":"Bile salts and their importance for drug absorption","volume":"453","author":"Holm","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107150_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfca.2021.104022","article-title":"Development and validation of a rapid method to quantify neutral lipids by NP-HPLC-charged aerosol detector","volume":"102","author":"Infantes-Garcia","year":"2021","journal-title":"J. Food Compos. Anal."},{"key":"10.1016\/j.ejps.2025.107150_bib0016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2019.04.003","article-title":"The mechanisms of pharmacokinetic food-drug interactions\u2014a perspective from the UNGAP group","volume":"134","author":"Koziolek","year":"2019","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"5","key":"10.1016\/j.ejps.2025.107150_bib0017","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s11095-014-1567-0","article-title":"Formulation and performance of danazol nano-crystalline suspensions and spray dried powders","volume":"32","author":"Kumar","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107150_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2024.01.009","article-title":"Evaluating utilization of tiny-TIM to assess the effect of food on the absorptions of oral drugs and its application on biopharmaceutical modeling","author":"Liu","year":"2024","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ejps.2025.107150_bib0019","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11095-020-02948-z","article-title":"Negative food effect of danirixin: use of PBPK modelling to explore the effect of formulation and meal type on clinical PK","volume":"37","author":"Lloyd","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107150_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106165","article-title":"Application of tiny-TIM as a mechanistic tool to investigate the in vitro performance of different itraconazole formulations under physiologically relevant conditions","volume":"173","author":"L\u00f3pez M\u00e1rmol","year":"2022","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2025.107150_bib0021","series-title":"The Impact of Food Bioactives On Health: In vitro and Ex Vivo Models","article-title":"The TNO gastro-intestinal model (TIM)","author":"Minekus","year":"2015"},{"issue":"1","key":"10.1016\/j.ejps.2025.107150_bib0022","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.xphs.2021.10.010","article-title":"In vitro simulation of the environment in the upper gastrointestinal lumen after drug administration in the fed state using the TIM-1 system and comparison with luminal data in adults","volume":"111","author":"Pentafragka","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107150_bib0023","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejpb.2020.02.003","article-title":"On the usefulness of compendial setups and tiny-TIM system in evaluating the in vivo performance of oral drug products with various release profiles in the fasted state: case example sodium salt of A6197","volume":"149","author":"Schilderink","year":"2020","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"issue":"9","key":"10.1016\/j.ejps.2025.107150_bib0024","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2165\/10895940-000000000-00000","article-title":"Clinical pharmacokinetics and pharmacodynamics of etravirine","volume":"48","author":"Sch\u00f6ller-Gy\u00fcre","year":"2009","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.ejps.2025.107150_bib0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/03639040601128654","article-title":"Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods and an artificial digestive system","volume":"33","author":"Souliman","year":"2007","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2025.107150_bib0026","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejps.2005.08.006","article-title":"A level A in vitro\/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form","volume":"27","author":"Souliman","year":"2006","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"8","key":"10.1016\/j.ejps.2025.107150_bib0027","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1021\/bi00460a011","article-title":"Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings","volume":"29","author":"Staggers","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2025.107150_bib0028","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cca.2016.08.014","article-title":"Where clinical chemistry meets medicinal chemistry. Systematic analysis of physico-chemical properties predicts stability of common used drugs in gel separator serum tubes","volume":"462","author":"Steuer","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.ejps.2025.107150_bib0029","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08037050152669738","article-title":"Comparison of the time courses and potencies of the vasodilator effects of nifedipine and felodipine in the human forearm","volume":"10","author":"van der Lee","year":"2001","journal-title":"Blood Press."},{"key":"10.1016\/j.ejps.2025.107150_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106043","article-title":"UNGAP best practice for improving solubility data quality of orally administered drugs","volume":"168","author":"Vertzoni","year":"2022","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2025.107150_bib0031","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2015.11.048","article-title":"Evaluation of two dynamic in vitro models simulating fasted and fed state conditions in the upper gastrointestinal tract (TIM-1 and tiny-TIM) for investigating the bioaccessibility of pharmaceutical compounds from oral dosage forms","volume":"498","author":"Verwei","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107150_bib0032","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.addr.2021.02.001","article-title":"Current challenges and future perspectives in oral absorption research: an opinion of the UNGAP network","volume":"171","author":"Vinarov","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.ejps.2025.107150_bib0033","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1021\/acs.molpharmaceut.8b00858","article-title":"Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations","volume":"15","author":"Williams","year":"2018","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.ejps.2025.107150_bib0034","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1021\/ac504689z","article-title":"Fast and sensitive total protein and peptide assays for proteomic analysis","volume":"87","author":"Wi\u015bniewski","year":"2015","journal-title":"Anal. Chem."},{"issue":"11","key":"10.1016\/j.ejps.2025.107150_bib0035","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1016\/j.xphs.2020.08.003","article-title":"Controlled solvent removal from antiviral drugs and excipients in solution enables the formation of novel combination multi-drug-motifs in pharmaceutical powders composed of Lopinavir, Ritonavir and Tenofovir","volume":"109","author":"Yu","year":"2020","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:24:11Z","timestamp":1762331051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725001496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":33,"alternative-id":["S0928098725001496"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107150","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tiny-TIM intestinal fluids versus human intestinal fluids: A comparison of their composition and solubilizing capacity for poorly soluble drugs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107150"}}